COSMED introduces Q-NRG, the new metabolic monitor for energy expenditure measurements in mechanically ventilated and spontaneous breathing patients in ICU

Posted on 08 March 2018, English, Company

indirect calorimetry

Rome (Italy) - March 2018 - COSMED, world-wide leader in the design of metabolic systems for clinical and human performance applications, announced today the release of a new product line of metabolic monitors for quick, accurate, intuitive and affordable indirect calorimetry.

COSMED introduit Q-NRG, un nouveau moniteur métabolique pour la mesures de la dépense énergétique chez les patients en respiration spontanée ou mécaniquement ventilés en soins intensifs

Posted on 08 March 2018, French

indirect calorimetry

Rome (Italie) - 8 mars 2018 - COSMED, leader mondial dans la conception de systèmes métaboliques en clinique, en recherche et en évaluation de la performance humaine, annonce aujourd'hui la sortie de sa nouvelle gamme de moniteurs métaboliques pour une calorimétrie indirecte rapide, précise, intuitive et abordable.

Does the use of indirect calorimetry change outcome in the ICU? Yes it does

Posted on 23 February 2018, COSMED News, English, Indirect Calorimetry, Scientific

indirect calorimetry

A new study appears on the "Current Opinion on Clinical Nutrition and Metabolic care Journal" highlighting the importance of monitoring nutrition and metabolic status of ICU patients.

Are Predictive Energy Expenditure Equations in Ventilated Surgery Patients Accurate?

Posted on 12 May 2017, COSMED News, English, Indirect Calorimetry, Scientific

indirect calorimetry

A new study in the Journal of Intensive care Medicine analyses the accuracy of predictive equations versus indirect calorimetry in surgical ICU (SICU) patients.

Resting energy expenditure in the risk assessment of anticancer treatments

Posted on 17 February 2017, Indirect Calorimetry, Scientific

indirect calorimetry

This study, published in the Clinical Nutrition Journal, tries to show how abnormal basal energy metabolism can be associated with higher risk in anticancer treatments (like chemotherapy).

<<  1 [23  >>